Book a DemoContact Us

L7 | CHATS

case study

Saying “No” to the Status Quo: How The Jackson Laboratory is Unlocking Research Excellence

by Steven Barash | posted on October 17, 2024

The Jackson Laboratory (JAX), known for pioneering genomics research and scientific leadership, needed to digitally enable their scientists to streamline their research operations and invest in the FAIRification of their scientific and operational data, where FAIRification ensures data is Findable, Accessible, Interoperable, and Reusable.

JAX, like many other prominent life science organizations, faced a common industry challenge: fragmented systems bred data silos across the organization’s multiple laboratories, slowing down scientists’ discovery. Fragmented systems, paper-based manual tracking, and disparate homegrown applications impeded scientific day-to-day research operations—solvable dilemmas no organization at the forefront of biomedical innovation should ignore.

As JAX planned to scale its operations and scientific expertise, it required an optimal solution that didn’t just band-aid the problem but transformed how it managed its research processes and data by implementing a platform purpose-built for end-to-end scientific operations. That’s where L7|ESP® came in—a unifying digital platform that enabled JAX to orchestrate and execute their scientific workflows, thereby contextualizing their data to unlock its full value.  

L7|ESP didn’t just organize JAX’s operations—it streamlined research operation inefficiencies, surfaced contextualized data, and resulted in significant savings and efficiencies, including:

  • 80% reduction in time spent on manual processes that were draining resources
  • Seamless integration across research teams, breaking down the silos that hindered collaboration
  • Alignment with FAIR principles, turning fragmented data into a cohesive, accessible research ecosystem
  • Consolidation of outdated applications, reducing the clutter and complexity

The Jackson Laboratory’s decision to move away from the status quo wasn’t just a technical upgrade—it was a strategic leap forward that reshaped its entire approach to research.

Curious to learn more and understand how they made the leap?

Download the case study here and discover how L7|ESP helped JAX turn inefficiency into innovation.

 

DOWNLOAD THE JAX CASE STUDY

ABOUT THE AUTHOR

Steven Barash, Vice President of Product Strategy & Development

Steven Barash is a dynamic manufacturing information systems thought leader spearheading digital manufacturing initiatives at L7 Informatics. Steven holds an established software implementation portfolio of regulated technology solutions in the cell and gene therapy manufacturing industry. Steven is committed to end-to-end automation of complex cell gene manufacturing operations to deliver personalized treatments to patients. He is focused on delivering unified enterprise data solutions to ease operational complexities, improve product quality, and digitally scale GMP commercial operations. Before L7 Informatics, Steven held various leadership and engineering roles at Charles River Labs, Cognate BioServices, TRC, Juno Therapeutics, Regeneron Pharmaceuticals, and AxoGen. Steven has a B.S. in Chemical Engineering from the University of Florida where he focused on translational research in immunomodulatory drug efficacy in preclinical animal models.